Sutro Biopharma, Inc

(NASDAQ:STRO)

Latest On Sutro Biopharma, Inc (STRO):

Date/Time Type Description Signal Details
2023-05-15 15:17 ESTNewsSutro Biopharma GAAP EPS of -$0.85, revenue of $12.7MN/A
2023-05-03 15:49 ESTNewsSutro, Mersana jump after Immunogen data for ovarian cancer therapyN/A
2023-04-11 19:04 ESTNewsSutro: Too Little, Too Late For STRO-002, But Platform Is InterestingN/A
2023-03-31 10:48 ESTNewsSutro Biopharma GAAP EPS of -$2.35 beats by $0.16, revenue of $67.8M misses by $0.57MN/A
2023-03-22 01:51 ESTNewsSutro Biopharma stock slides as transferred to Equal Weight at Wells FargoN/A
2023-02-28 10:05 ESTNewsSutro Biopharma appoints Borgman as Chief Medical OfficerN/A
2022-12-20 18:43 ESTNewsVaxcyte acquires option from Sutro Biopharma to expand rights to make cell-free extractN/A
2022-11-08 19:34 ESTNewsSutro Biopharma GAAP EPS of -$0.37 misses by $0.08, revenue of $25.14M misses by $10.62MN/A
2022-08-16 14:27 ESTNewsSutro Biopharma: Partnership Progress Warrants ExposureN/A
2022-08-09 08:23 ESTNewsSutro Biopharma GAAP EPS of -$0.55, revenue of $28.1MN/A
2022-07-26 21:24 ESTNewsSutro to get $10M payment from Merck after first patient dosed in collaboration trialN/A
2022-06-28 10:31 ESTNewsSutro Biopharma soars ~50% after announcing worldwide strategic collaboration with Astellas PharmaN/A
2022-05-09 17:15 ESTNewsSutro Biopharma GAAP EPS of -$0.84 misses by $0.08, revenue of $5.89M misses by $4.57MN/A
2022-02-28 19:19 ESTNewsSutro Biopharma GAAP EPS of -$2.29 misses by $0.13, revenue of $61.88M beats by $0.16MN/A
2022-01-06 18:39 ESTNewsSutro at a 52-week low as analysts weigh in on safety data for cancer drugN/A
2022-01-06 02:58 ESTNewsSutro posts early-stage data for ovarian cancer drug indicating 33% ORRN/A
2021-12-27 20:30 ESTNewsSutro Bio inks licensing deal for STRO-002 in Greater ChinaN/A
2021-12-27 20:30 ESTNewsSutro; A Biotech To Watch With A Catalyst Rapidly ApproachingN/A
2021-12-06 22:52 ESTNewsSutro Biopharma (STRO) Presents At 4th Annual Evercore ISI HealthCONx Conference - SlideshowN/A
2021-12-06 22:52 ESTNewsSutro Biopharma (STRO) Presents At Piper Sandler 33rd Annual Virtual Healthcare Conference - SlideshowN/A
2021-12-06 22:52 ESTNewsSutro Biopharma (STRO) Presents At Jefferies London Healthcare Conference - SlideshowN/A
2021-11-23 08:45 ESTNewsSutro Biopharma (STRO) Presents At 2021 Virtual Healthcare Conference - SlideshowN/A
2021-11-10 16:26 ESTNewsSutro Biopharma EPS misses by $0.02, misses on revenueN/A
2021-10-12 13:29 ESTNewsSutro Biopharma and BioNova ink collaboration agreement for STRO-001 in Greater ChinaN/A
2021-10-01 22:07 ESTNewsSutro Biopharma and Merck extend research term for cytokine derivative programN/A
2021-09-11 04:32 ESTNewsSutro Biopharma (STRO) Presents At 2021 Virtual Wells Fargo Healthcare ConferenceN/A
2021-08-18 17:50 ESTNewsSutro Biopharma nabs FDA Fast Track Designation for ovarian cancer therapyN/A
2021-08-09 15:28 ESTNewsSutro Biopharma reports Q2 resultsN/A
2021-07-22 02:42 ESTNewsSutro Biopharma initiated buy at H.C. Wainwright citing ADC candidatesN/A
2021-05-07 16:03 ESTNewsSutro Biopharma EPS misses by $0.04, beats on revenueN/A
2021-04-16 02:20 ESTNewsSutro Biopharma (STRO) Presents At 20th Annual Needham Virtual Healthcare Conference - SlideshowN/A
2021-04-15 08:22 ESTNewsSutro Biopharma earns milestone payment from Merck collaborationN/A
2021-03-19 02:57 ESTNewsSutro Biopharma EPS misses by $1.07, revenue in-lineN/A
2021-03-03 12:30 ESTAnalyst RatingThe Analyst Target Price has decreased from $31.14 to $29.43.Neutral
2021-02-24 14:49 ESTNewsBristol-Myers receives FDA’s orphan drug designation for multiple myeloma therapyN/A
2021-01-29 08:37 ESTAnalyst RatingThe Analyst Target Price has increased from $29.29 to $31.14.Buy
2021-01-22 08:39 ESTAnalyst RatingThe Analyst Target Price has increased from $28.57 to $29.29.Buy
2021-01-21 14:56 ESTNewsDosing underway in Sutro Biopharma's early-stage ovarian cancer trial with STRO-002N/A
2021-01-06 11:06 ESTNewsSutro: Leading Cell Free Protein Synthesis Company With Promising Early DataN/A
2020-12-15 13:03 ESTAnalyst RatingThe Analyst Target Price has increased from $27.57 to $28.57.Buy
2020-12-11 12:45 ESTAnalyst RatingThe Analyst Target Price has increased from $26.86 to $27.57.Buy
2020-12-09 07:03 ESTNewsSutro Biopharma (STRO) Investor Presentation - SlideshowN/A
2020-12-09 07:03 ESTNewsSutro Biopharma prices $126M public offeringN/A
2020-12-08 12:46 ESTNewsSutro Biopharma down after STRO-001 data in blood cancer studyN/A
2020-12-08 12:46 ESTNewsSutro Biopharma -4.6% after filing to offer 5M sharesN/A
2020-12-07 21:12 ESTAnalyst RatingThe Analyst Target Price has increased from $21.57 to $26.86.Buy
2020-12-04 12:27 ESTNewsSutro +23.5% as ovarian cancer drug study offers encouraging interim dataN/A
2020-12-04 09:03 ESTAnalyst RatingThe Analyst Target Price has increased from $21 to $21.57.Neutral
2020-11-28 06:08 ESTNewsSeeking Alpha Catalyst WatchN/A
2020-11-26 21:40 ESTFinancialsCompany financials have been released.Neutral

About Sutro Biopharma, Inc (STRO):

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers. It has collaboration and license agreement with Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused primarily on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

STRO Quotes by TradingView

See Advanced Chart

General

  • Name Sutro Biopharma, Inc
  • Symbol STRO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 182
  • Fiscal Year EndDecember
  • IPO Date2018-09-27
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.sutrobio.com
View More

Valuation

  • Trailing PE 54.26
  • Price/Sales (Trailing 12 Mt.) 14.95
  • Price/Book (Most Recent Quarter) 4.48
  • Enterprise Value Revenue 18.27
  • Enterprise Value EBITDA 41.71
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.56
  • Profit Margin 28%
  • Operating Margin -134%
  • Return on Assets -16%
  • Return on Equity 7%
  • Revenue 45.75 million
  • Earnings Per Share $0.44
  • Revenue Per Share $1.62
  • Gross Profit -22876000
  • Quarterly Earnings Growth 45.2%
View More

Highlights

  • Market Capitalization 1.09 billion
  • EBITDA -36933000
  • PE Ratio -3.01
  • Analyst Target Price $29.43
  • Book Value Per Share $6.41
View More

Share Statistics

  • Shares Outstanding 45.61 million
  • Shares Float 34.47 million
  • % Held by Insiders 1111%
  • % Held by Institutions 88.44%
  • Shares Short 1.14 million
  • Shares Short Prior Month 1.03 million
  • Short Ratio 2.56
  • Short % of Float 3%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 0.79
  • 52 Week High $28.3
  • 52 Week Low $6.91
  • 50 Day Moving Average 23.26
  • 200 Day Moving Average 18.4
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Sutro Biopharma, Inc (STRO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Sutro Biopharma, Inc (STRO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$17.82 million$0.45-$0.51188.74%
2020-06-302020-08-06$N/A$0.94-$0.64246.01%
2020-03-312020-05-11$7.15 million-$0.84-$0.69-21.99%
2019-12-312020-03-16$11.31 million-$0.64-$0.697.81%
2019-09-302019-11-08$12.28 million-$0.56-$0.6514.45%
2019-06-302019-08-14$10.53 million-$0.60-$0.623.41%
2019-03-312019-05-15$8.63 million-$0.62-$0.61-2.06%
2018-12-312018-12-31$19.09 million-$0.26-$0.6358.73%
2018-09-302018-11-14$7.84 million-$0.45-$0.8547.5%

Sutro Biopharma, Inc (STRO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development 19.36 million N/A 17.62 million N/A 16.9 million
Income Before Tax 17.14 million N/A -19.6 million -14.79 million -12.91 million
Selling General Administrative 9.08 million N/A 8.71 million 8.7 million 8.12 million
Gross Profit N/A N/A N/A -6.09 million 12.28 million
Ebit 20.42 million N/A -17.44 million -14.93 million -12.74 million
Operating Income -10.62 million N/A -19.18 million -14.93 million -12.74 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue 17.82 million N/A 7.15 million 11.31 million 12.28 million
Cost of Revenue N/A N/A N/A 17.39 million N/A
Total Other Income Expense Net 29.78 million N/A N/A 138000 -177000
Net Income From Continuing Operations 17.14 million N/A -19.6 million -14.79 million -12.91 million
Net Income Applicable to Common Shares N/A 29.87 million -19.6 million -14.79 million -12.91 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments 296000 N/A 41.64 million 9.99 million 10.48 million
Change to Liabilities N/A -5.89 million N/A -3.66 million -6.69 million
Total Cash Flow from Investing Activities N/A -57.14 million N/A 7.94 million 9.81 million
Net Borrowings N/A N/A N/A -1.5 million -1.5 million
Total Cash Flow from Financial Activities 17.27 million N/A 15.7 million -1.78 million -1.13 million
Change to Operating Activities N/A 1.92 million N/A 197000 444000
Change in Cash -121000 N/A 38.61 million -6.99 million -7.44 million
Total Cash from Operating Activities -17.69 million -12.5 million -18.73 million -13.16 million -16.12 million
Depreciation 967000 N/A 1.1 million 1.22 million 1.23 million
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables -2.38 million N/A -2.78 million 1.23 million -1.03 million
Other Cash Flow from Financing Activities N/A N/A N/A -327000 N/A
Change to Net Income N/A -43.44 million N/A 2.45 million 2.84 million
Capital Expenditures 2.98 million N/A 763000 2.05 million 667000
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities 63.12 million N/A 71.79 million 58.58 million 61.77 million
Total Stockholder Equity 244.12 million N/A 82.09 million 97.79 million 109.91 million
Other Current Liabilities 3.44 million N/A 352000 20.37 million 20.84 million
Total Assets 307.24 million N/A 153.88 million 156.37 million 171.68 million
Common Stock N/A 36000 23000 23000 23000
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -168.33 million -185.47 million -215.34 million -195.75 million -180.96 million
Other Liabilities N/A 11.04 million N/A 16.74 million 20.41 million
Other Assets N/A 2.14 million 2.7 million 2.56 million 2.37 million
Cash 64.37 million N/A 43.57 million 4.96 million 11.95 million
Total Current Liabilities 29.91 million N/A 32.01 million 32.97 million 35.86 million
Other Stockholder Equity N/A 398000 28000 165000 223000
Property, Plant & Equipment N/A 11.27 million 9.53 million 9.63 million 8.52 million
Total Current Assets 292.3 million N/A 127.46 million 128.57 million 135.57 million
Long Term Investments N/A N/A 14.19 million 15.61 million 25.22 million
Net Tangible Assets N/A 206.76 million N/A 97.79 million 109.91 million
Short Term Investments 216.86 million N/A 71.83 million 112.9 million 113.21 million
Long Term Debt 24.41 million N/A 24.16 million 8.88 million 5.5 million
Inventory N/A N/A N/A N/A N/A
Accounts Payable 4.88 million N/A 5.84 million 5.58 million 4.55 million

Sutro Biopharma, Inc (STRO) Chart:

Sutro Biopharma, Inc (STRO) News:

Below you will find a list of latest news for Sutro Biopharma, Inc (STRO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Sutro Biopharma, Inc (STRO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-07-17150CALL0 0126.05TRUE00
2026-07-1717.50CALL0 2157.83TRUE00
2026-07-17200CALL0 0135.48TRUE00
2026-07-1722.50CALL0 0129.87TRUE00
2026-07-17250CALL0 50128.39TRUE00
2026-07-17300CALL0 0112.94FALSE00
2026-07-17350CALL0 19129.7FALSE00
2026-07-17400CALL0 1160.34FALSE00
2026-07-17450CALL0 0181.28FALSE00
2026-07-17500CALL0 0202.38FALSE00
2026-07-17550CALL0 0220.07FALSE00
2026-07-17600CALL0 0235.2FALSE00
2026-07-17150PUT0 0299.9FALSE00
2026-07-1717.50PUT0 0254.14FALSE00
2026-07-17200PUT0 2215.18FALSE00
2026-07-1722.50PUT0 1193.93FALSE00
2026-07-17250PUT0 2146.77FALSE00
2026-07-17300PUT0 0139.04TRUE00
2026-07-17350PUT0 0144.15TRUE00
2026-07-17400PUT0 0147.81TRUE00
2026-07-17450PUT0 0156.75TRUE00
2026-07-17500PUT0 0163.96TRUE00
2026-07-17550PUT0 0175.2TRUE00
2026-07-17600PUT0 0191.26TRUE00
2026-08-212.50CALL0 10TRUE00
2026-08-2150CALL0 0214.17TRUE00
2026-08-217.50CALL0 0160.87TRUE00
2026-08-21100CALL0 3123.83TRUE00
2026-08-2112.50CALL0 0157.93TRUE00
2026-08-21150CALL0 2140.7TRUE00
2026-08-2117.50CALL0 6134.8TRUE00
2026-08-21200CALL0 16123.09TRUE00
2026-08-2122.50CALL0 2125.27TRUE00
2026-08-21250CALL0 3120.72TRUE00
2026-08-21300CALL0 7113.61FALSE00
2026-08-21354CALL0 7117.36FALSE00
2026-08-21400CALL0 1114.98FALSE00
2026-08-21450CALL0 0128.43FALSE00
2026-08-21500CALL0 0144.13FALSE00
2026-08-21550CALL0 7157.56FALSE00
2026-08-21600CALL0 0169.3FALSE00
2026-08-212.50PUT0 0989.28FALSE00
2026-08-2150PUT0 0522.69FALSE00
2026-08-217.50PUT0 0388.99FALSE00
2026-08-21100PUT0 2313.29FALSE00
2026-08-2112.50PUT0 4261.96FALSE00
2026-08-21150PUT0 1221.69FALSE00
2026-08-2117.50PUT0 3184.57FALSE00
2026-08-21202.05PUT0 5152.74FALSE00
2026-08-2122.52.85PUT1 1131.35FALSE-0.05-0.02
2026-08-21250PUT0 6129.99FALSE00
2026-08-21300PUT0 0133.57TRUE00
2026-08-21350PUT0 0134.15TRUE00
2026-08-21400PUT0 0134.01TRUE00
2026-08-21450PUT0 0132.15TRUE00
2026-08-21500PUT0 0136.4TRUE00
2026-08-21550PUT0 0121.7TRUE00
2026-08-21600PUT0 0148.46TRUE00
2026-11-2012.50CALL0 0138.85TRUE00
2026-11-20150CALL0 0128.44TRUE00
2026-11-2017.50CALL0 0129.32TRUE00
2026-11-20200CALL0 2124.78TRUE00
2026-11-2022.50CALL0 1122.22TRUE00
2026-11-20250CALL0 0121.15TRUE00
2026-11-20300CALL0 7114.46FALSE00
2026-11-20350CALL0 8113.33FALSE00
2026-11-20400CALL0 4110.02FALSE00
2026-11-20450CALL0 5113.19FALSE00
2026-11-20500CALL0 0111.79FALSE00
2026-11-20550CALL0 0111.63FALSE00
2026-11-20600CALL0 0111.91FALSE00
2026-11-2012.50PUT0 2172.83FALSE00
2026-11-20150PUT0 6149.08FALSE00
2026-11-2017.50PUT0 5129.06FALSE00
2026-11-20200PUT0 1125.23FALSE00
2026-11-2022.50PUT0 0125.35FALSE00
2026-11-20250PUT0 3124.11FALSE00
2026-11-20300PUT0 3122.81TRUE00
2026-11-20350PUT0 0121.26TRUE00
2026-11-20400PUT0 0121.06TRUE00
2026-11-20450PUT0 0122.29TRUE00
2026-11-20500PUT0 4120.35TRUE00
2026-11-20550PUT0 0123.18TRUE00
2026-11-20600PUT0 0124.51TRUE00
2027-02-19150CALL0 0117.51TRUE00
2027-02-1917.50CALL0 0114.46TRUE00
2027-02-19200CALL0 0117.01TRUE00
2027-02-1922.50CALL0 0115.1TRUE00
2027-02-19250CALL0 0114.65TRUE00
2027-02-19300CALL0 0109.43FALSE00
2027-02-19350CALL0 0110.69FALSE00
2027-02-19400CALL0 0109.68FALSE00
2027-02-19450CALL0 0110.23FALSE00
2027-02-19150PUT0 0123.7FALSE00
2027-02-1917.50PUT0 0116.2FALSE00
2027-02-19200PUT0 0121.69FALSE00
2027-02-1922.50PUT0 0118.64FALSE00
2027-02-19250PUT0 0116.61FALSE00
2027-02-19300PUT0 0115.74TRUE00
2027-02-19350PUT0 0115.92TRUE00
2027-02-19400PUT0 0114.54TRUE00
2027-02-19450PUT0 0114.75TRUE00

Latest STRO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST220$3.585
Jun 13, 2022 7:59 PM EST84$3.585
Jun 13, 2022 7:59 PM EST100$3.585
Jun 13, 2022 7:59 PM EST65$3.585
Jun 13, 2022 7:59 PM EST10$3.585

Sutro Biopharma, Inc (STRO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120039220/0001209191-20-039220-index.htm
2019-10-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1382101/000000000019014405/0000000000-19-014405-index.htm
2020-05-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000092189520001581/0000921895-20-001581-index.htm
2020-08-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000093583620000485/0000935836-20-000485-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000110465918059933/0001104659-18-059933-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000110465918060241/0001104659-18-060241-index.htm
2018-10-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465918060573/0001104659-18-060573-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920013796/0001104659-20-013796-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920019043/0001104659-20-019043-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920020195/0001104659-20-020195-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920021714/0001104659-20-021714-index.htm
2020-08-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000110465920098064/0001104659-20-098064-index.htm
2018-10-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000114420418052437/0001144204-18-052437-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000114420419006659/0001144204-19-006659-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000114420419008119/0001144204-19-008119-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000114420419008329/0001144204-19-008329-index.htm
2018-10-09SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1382101/000119312518295955/0001193125-18-295955-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000119312518322690/0001193125-18-322690-index.htm
2018-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000119312518326967/0001193125-18-326967-index.htm
2019-10-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1382101/000119312519262726/0001193125-19-262726-index.htm
2019-10-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1382101/000119312519265124/0001193125-19-265124-index.htm
2019-10-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1382101/000119312519266765/0001193125-19-266765-index.htm
2020-05-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1382101/000119312520139053/0001193125-20-139053-index.htm
2020-05-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1382101/000119312520140570/0001193125-20-140570-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052480/0001209191-18-052480-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052481/0001209191-18-052481-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052482/0001209191-18-052482-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052483/0001209191-18-052483-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052487/0001209191-18-052487-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052490/0001209191-18-052490-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052491/0001209191-18-052491-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052492/0001209191-18-052492-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052493/0001209191-18-052493-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052495/0001209191-18-052495-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052496/0001209191-18-052496-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052826/0001209191-18-052826-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052831/0001209191-18-052831-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052833/0001209191-18-052833-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052835/0001209191-18-052835-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052837/0001209191-18-052837-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052839/0001209191-18-052839-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052841/0001209191-18-052841-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052843/0001209191-18-052843-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052848/0001209191-18-052848-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118052851/0001209191-18-052851-index.htm
2018-11-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118058332/0001209191-18-058332-index.htm
2018-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919118058335/0001209191-18-058335-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006200/0001209191-19-006200-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006201/0001209191-19-006201-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006202/0001209191-19-006202-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006203/0001209191-19-006203-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006204/0001209191-19-006204-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006206/0001209191-19-006206-index.htm
2019-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119006208/0001209191-19-006208-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119010244/0001209191-19-010244-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038094/0001209191-19-038094-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038097/0001209191-19-038097-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038100/0001209191-19-038100-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038101/0001209191-19-038101-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038102/0001209191-19-038102-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119038103/0001209191-19-038103-index.htm
2019-06-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119039122/0001209191-19-039122-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119039123/0001209191-19-039123-index.htm
2019-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119047755/0001209191-19-047755-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119048831/0001209191-19-048831-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051116/0001209191-19-051116-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051117/0001209191-19-051117-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051118/0001209191-19-051118-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051119/0001209191-19-051119-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051122/0001209191-19-051122-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119051124/0001209191-19-051124-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119054572/0001209191-19-054572-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119058353/0001209191-19-058353-index.htm
2019-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919119062036/0001209191-19-062036-index.htm
2020-01-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120002565/0001209191-20-002565-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120002569/0001209191-20-002569-index.htm
2020-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005159/0001209191-20-005159-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005798/0001209191-20-005798-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005806/0001209191-20-005806-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005808/0001209191-20-005808-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005810/0001209191-20-005810-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005812/0001209191-20-005812-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120005814/0001209191-20-005814-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120013478/0001209191-20-013478-index.htm
2020-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120021438/0001209191-20-021438-index.htm
2020-04-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120025882/0001209191-20-025882-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120029243/0001209191-20-029243-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120029244/0001209191-20-029244-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120029246/0001209191-20-029246-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120032414/0001209191-20-032414-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035026/0001209191-20-035026-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035027/0001209191-20-035027-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035028/0001209191-20-035028-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035030/0001209191-20-035030-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035036/0001209191-20-035036-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035037/0001209191-20-035037-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120035058/0001209191-20-035058-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120039220/0001209191-20-039220-index.htm
2020-07-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120043857/0001209191-20-043857-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120047981/0001209191-20-047981-index.htm
2020-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120048538/0001209191-20-048538-index.htm
2020-09-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120050511/0001209191-20-050511-index.htm
2020-09-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120051490/0001209191-20-051490-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052243/0001209191-20-052243-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052244/0001209191-20-052244-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052245/0001209191-20-052245-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052247/0001209191-20-052247-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120052248/0001209191-20-052248-index.htm
2020-10-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120054025/0001209191-20-054025-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000120919120057311/0001209191-20-057311-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1382101/000141588918001458/0001415889-18-001458-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459018029555/0001564590-18-029555-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1382101/000156459019010253/0001564590-19-010253-index.htm
2019-04-01S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1382101/000156459019010261/0001564590-19-010261-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019010338/0001564590-19-010338-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1382101/000156459019013160/0001564590-19-013160-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1382101/000156459019013167/0001564590-19-013167-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019016067/0001564590-19-016067-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459019019236/0001564590-19-019236-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019019255/0001564590-19-019255-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019022125/0001564590-19-022125-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019022611/0001564590-19-022611-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019023255/0001564590-19-023255-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459019031883/0001564590-19-031883-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019031936/0001564590-19-031936-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019038415/0001564590-19-038415-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459019041909/0001564590-19-041909-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459019042019/0001564590-19-042019-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020000514/0001564590-20-000514-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020008232/0001564590-20-008232-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1382101/000156459020010890/0001564590-20-010890-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020010955/0001564590-20-010955-index.htm
2020-03-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1382101/000156459020011175/0001564590-20-011175-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1382101/000156459020018532/0001564590-20-018532-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020018684/0001564590-20-018684-index.htm
2020-05-0410-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1382101/000156459020020872/0001564590-20-020872-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459020023689/0001564590-20-023689-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020024242/0001564590-20-024242-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020024736/0001564590-20-024736-index.htm
2020-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020028506/0001564590-20-028506-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020029235/0001564590-20-029235-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459020036997/0001564590-20-036997-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020037231/0001564590-20-037231-index.htm
2020-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020042563/0001564590-20-042563-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020043014/0001564590-20-043014-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1382101/000156459020050755/0001564590-20-050755-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1382101/000156459020050851/0001564590-20-050851-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1382101/000158064219000779/0001580642-19-000779-index.htm
2019-10-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1382101/999999999519002305/9999999995-19-002305-index.htm

Sutro Biopharma, Inc (STRO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sutro Biopharma, Inc (STRO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1111%
Institutional Ownership: 8844%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-26WILLIAM J NEWELLCEOBuy25,252.00119,337.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051124/0001209191-19-051124-index.htm
2020-05-14ARTURO MD MOLINAChief Medical OfficerBuy6,451.007.7549,995.2512,083.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120029244/0001209191-20-029244-index.htm
2020-09-25EDWARD C ALBINICFO and SecretaryBuy7,174.0013,556.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052243/0001209191-20-052243-index.htm
2020-09-25Anik ShabbirChief Technical Ops. OfficerBuy8,609.0014,241.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052244/0001209191-20-052244-index.htm
2020-08-19John Gordon FreundDirectorSell500,000.008.724,360,000.001,460,053.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120047981/0001209191-20-047981-index.htm
2020-09-25LINDA A FITZPATRICKChief People & Comm. OfficerBuy7,576.0016,583.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052245/0001209191-20-052245-index.htm
2020-05-14WILLIAM J NEWELLCEOBuy64,516.007.75499,999.00166,627.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120029246/0001209191-20-029246-index.htm
2020-08-26Trevor HallamChief Scientific OfficerSell975.009.048,818.2916,790.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120048538/0001209191-20-048538-index.htm
2020-07-27Trevor HallamChief Science OfficerSell975.008.067,858.2117,765.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120043857/0001209191-20-043857-index.htm
2020-06-26Trevor HallamChief Science OfficerSell975.008.027,817.6518,740.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120039220/0001209191-20-039220-index.htm
2020-09-25WILLIAM J NEWELLCEOBuy25,252.00191,879.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052248/0001209191-20-052248-index.htm
2018-10-01Daniel H PetreeDirectorSell122.0015.001,830.00192.00https://www.sec.gov/Archives/edgar/data/1382101/000120919118052843/0001209191-18-052843-index.htm
2020-05-26Trevor HallamChief Science OfficerSell975.0010.009,753.3219,715.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120032414/0001209191-20-032414-index.htm
2020-04-27Trevor HallamChief Science OfficerSell2.0011.1922.3820,690.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120025882/0001209191-20-025882-index.htm
2020-09-25ARTURO MD MOLINAChief Medical OfficerBuy8,609.0020,692.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052247/0001209191-20-052247-index.htm
2020-04-27Trevor HallamChief Science OfficerSell973.009.419,160.5020,692.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120025882/0001209191-20-025882-index.htm
2020-03-26Trevor HallamChief Science OfficerSell975.009.699,452.5321,665.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120021438/0001209191-20-021438-index.htm
2020-02-26Trevor HallamChief Science OfficerSell975.0010.4710,207.2822,640.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120013478/0001209191-20-013478-index.htm
2020-01-27Trevor HallamChief Science OfficerSell975.0010.5110,250.3723,615.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120005159/0001209191-20-005159-index.htm
2019-12-26Trevor HallamChief Science OfficerSell975.0011.0810,802.2224,590.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119062036/0001209191-19-062036-index.htm
2019-11-26Trevor HallamChief Science OfficerSell975.0010.6810,410.2725,565.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119058353/0001209191-19-058353-index.htm
2019-10-28Trevor HallamChief Science OfficerSell975.009.989,726.1126,540.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119054572/0001209191-19-054572-index.htm
2019-09-26Trevor HallamChief Science OfficerBuy11,019.0026,819.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051119/0001209191-19-051119-index.htm
2018-10-01Merck & Co., Inc.10% Share HolderBuy666,666.0015.009,999,990.002,723,509.00https://www.sec.gov/Archives/edgar/data/1382101/000110465918059933/0001104659-18-059933-index.htm
2020-09-28Trevor HallamChief Scientific OfficerSell975.0010.2610,006.7227,530.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm
2020-09-25Trevor HallamChief Scientific OfficerBuy11,019.0027,809.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm
2019-09-26Trevor HallamChief Science OfficerBuy6,887.0029,896.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051119/0001209191-19-051119-index.htm
2019-02-12Daniel H PetreeDirectorBuy3,030.005.0915,422.703,030.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119010244/0001209191-19-010244-index.htm
2020-09-25Trevor HallamChief Scientific OfficerBuy6,887.0030,886.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120052246/0001209191-20-052246-index.htm
2018-10-01Daniel H PetreeDirectorBuy314.005.811,824.34314.00https://www.sec.gov/Archives/edgar/data/1382101/000120919118052843/0001209191-18-052843-index.htm
2020-10-05Trevor HallamChief Scientific OfficerBuy9,182.004.3640,033.5236,712.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120054025/0001209191-20-054025-index.htm
2020-11-05Trevor HallamChief Scientific OfficerSell16,751.0015.00251,265.0036,712.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120057311/0001209191-20-057311-index.htm
2019-09-06Daniel H PetreeDirectorBuy826.005.094,204.343,856.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119048831/0001209191-19-048831-index.htm
2020-11-05Trevor HallamChief Scientific OfficerBuy16,751.004.3673,034.3653,463.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120057311/0001209191-20-057311-index.htm
2020-09-18John Gordon FreundDirectorSell400,000.0012.004,800,000.00560,053.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120051490/0001209191-20-051490-index.htm
2019-08-29LINDA A FITZPATRICKChief People & Comm. OfficerBuy826.005.094,204.34826.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119047755/0001209191-19-047755-index.htm
2019-09-26LINDA A FITZPATRICKChief People & Comm. OfficerBuy7,575.008,401.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051118/0001209191-19-051118-index.htm
2019-09-26Anik ShabbirChief Technical Ops. OfficerBuy8,608.008,608.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051117/0001209191-19-051117-index.htm
2019-09-26ARTURO MD MOLINAChief Medical OfficerBuy8,608.008,608.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051122/0001209191-19-051122-index.htm
2019-09-26EDWARD C ALBINICFO and SecretaryBuy7,174.008,862.00https://www.sec.gov/Archives/edgar/data/1382101/000120919119051116/0001209191-19-051116-index.htm
2020-05-14LINDA A FITZPATRICKChief People & Comm. OfficerBuy3,225.007.7524,993.759,007.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120029243/0001209191-20-029243-index.htm
2020-09-11John Gordon FreundDirectorSell500,000.0010.005,000,000.00960,053.00https://www.sec.gov/Archives/edgar/data/1382101/000120919120050511/0001209191-20-050511-index.htm